In addition, we identified four other pathways significantly associated with BCC risk as defined by the KEGG and BioCarta databases: the heparan sulfate biosynthesis pathway, the mCalpain pathway, the Rho cell motility signaling pathway, and the nitric oxide pathway. The gene discussed is RHO; the disease is skin basal cell carcinoma.